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CHARGE syndrome is caused by spontaneous loss-of-function mutations to the ATP-dependant chro-
matin remodeller chromodomain-helicase-DNA-binding protein 7 (CHD7). It is characterised by a dis-
tinct pattern of congenital anomalies, including cardiovascular malformations. Disruption to the neural
crest lineage has previously been emphasised in the aetiology of this developmental disorder. We pre-
sent evidence for an additional requirement for CHD7 activity in the Mesp1-expressing anterior meso-
derm during heart development. Conditional ablation of Chd7 in this lineage results in major structural
cardiovascular defects akin to those seen in CHARGE patients, as well as a striking loss of cardiac in-
nervation and embryonic lethality. Genome-wide transcriptional analysis identified aberrant expression
of key components of the Class 3 Semaphorin and Slit–Robo signalling pathways in Chd7fl/fl;Mesp1-Cre
mutant hearts. CHD7 localises at the Sema3c promoter in vivo, with alteration of the local chromatin
structure seen following Chd7 ablation, suggestive of direct transcriptional regulation. Furthermore, we
uncover a novel role for CHD7 activity upstream of critical calcium handling genes, and demonstrate an
associated functional defect in the ability of cardiomyocytes to undergo excitation–contraction coupling.
This work therefore reveals the importance of CHD7 in the cardiogenic mesoderm for multiple processes
during cardiovascular development.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Heart development involves a series of tightly-regulated mor-
phological changes, from the early establishment of a linear tube
to looping, chamber formation, and septation (Buckingham et al.,
2005). The importance of epigenetic regulation of gene expression
programmes during this complex process is becoming increasingly
apparent, with a range of chromatin-remodelling and histone-
modifying factors now identified with roles in cardiovascular de-
velopment and disease (Chang and Bruneau, 2012). Chromodo-
main-helicase-DNA-binding protein 7 (CHD7) is a large ATP-de-
pendant nucleosome-remodelling protein. It co-localises with
mono- and tri-methylated lysine 4 on histone H3 (Schnetz et al.,
2009), and shows a high level of co-occupancy with p300 binding
sites in embryonic stem cells, indicating it may regulate gene ex-
pression through enhancer-binding (Schnetz et al., 2010). Chro-
matin remodelling by CHD7 is involved in the transcriptionalr Inc. This is an open access article
r).regulation of key developmental processes, including great vessel
morphogenesis (Randall et al., 2009), neural crest cell (NCC) for-
mation (Bajpai et al., 2010), and neuronal differentiation (Engelen
et al., 2011; Layman et al., 2009).
Haploinsufficiency for CHD7 causes human CHARGE syndrome
in over 90% of clinical cases (Vissers et al., 2004). CHARGE is a
developmental disorder characterised by a specific pattern of de-
fects, including ocular coloboma, heart malformations, atresia of
the choanae, growth retardation, genital hypoplasia and ear ab-
normalities (Hall, 1979). A wide range of congenital heart defects
are seen in approximately 74–77% of CHARGE patients (Zentner
et al., 2010; Corsten-Janssen et al., 2013), with an over-
representation of atrioventricular septal defects (AVSDs) and out-
flow tract (OFT) defects (Corsten-Janssen et al., 2013). CHD7 mu-
tations have also been detected in a large-scale study of de novo
mutations in human sporadic congenital heart defects (Zaidi et al.,
2013).
Investigation of Chd7-null embryos indicates that CHD7 inter-
acts with BMP-activated SMAD1/5/8 to regulate expression of
cardiogenic BMP target genes such as Nkx2.5, Gata4 and Tbx20
during early cardiogenesis and chamber formation (Liu et al.,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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10.5 due to p53-dependant growth failure (Van Nostrand et al.,
2014), limiting a full assessment of heart development. Chd7þ /
mice are viable and phenocopy a number of aspects of CHARGE
syndrome, including partial penetrance of ventricular septal de-
fects (VSDs) and interrupted aortic arch type B (IAA-B) (Randall
et al., 2009; Bosman et al., 2005; Hurd et al., 2007), although the
full spectrum and severity of CHARGE cardiovascular malforma-
tions are not seen. We have therefore utilised a conditional
knockdown model to investigate further the role of CHD7 and its
tissue-specific requirements during heart development.
There are three known developmental origins for the cells that
make up the mature heart: the cardiogenic mesoderm, fromwhich
the myocardium and endocardium are derived (Saga et al., 1999);
cardiac NCCs, which contribute to OFT septation and great vessel
development (Creazzo et al., 1998; Waldo et al., 2005); and the
proepicardial organ, which provides components of the coronary
vasculature system (Merki et al., 2005). CHARGE syndrome is often
classified as a disease arising from maldevelopment of NCCs,
known as a neurocristopathy (Etchevers et al., 2006), and CHD7
activity has been shown to have an essential role in the activation
of the NCC transcriptional circuitry (Bajpai et al., 2010). We show
for the first time that loss of Chd7 in the early cardiogenic meso-
derm, driven by Mesp1-Cre, results in major structural defects and
gene dysregulation, leading to cardiac failure and embryonic
lethality around E15.5. Endocardial-specific ablation of Chd7 also
results in septation and great vessel defects, indicating disruption
to endocardium development is contributing to these malforma-
tions. CHD7 action lies upstream of key extracellular signalling
molecules, including components of the Semaphorin and Slit–
Robo pathways, as well as cardiac calcium handling genes, with
consequences for excitation–contraction coupling in cardiomyo-
cytes. Together, these results indicate that disruption to CHD7
activity in the cardiogenic mesoderm significantly contributes to
the cardiovascular malformations seen in CHARGE patients.Fig. 1. Major cardiovascular defects in Chd7fl/fl;Mesp1-Cre embryos. (A) At E15.5, Chd7fl/
pared to littermate Chd7fl/fl controls. (B) Normal great vessel configuration was seen in Ch
arch type B (IAA-B) when examined at E15.5 (star). India ink injection was used on the
injection at E10.5 was used to visualise the developing left and right 3rd, 4th and 6th ph
panel) embryos. All Chd7fl/fl;Mesp1-Cre embryos examined showed normal PAA developm
right/left subclavian artery; rcc/lcc, right/left common carotid artery; aa, aortic arch; oft, ou2. Results and discussion
2.1. Embryonic lethality and great vessel defects following meso-
dermal ablation of Chd7
Mice homozygous for a conditional floxed Chd7 allele (Chd7fl/fl)
were crossed with Chd7fl/þ;Mesp1-Cre mice, to homozygously ablate
Chd7 expression in the anterior mesoderm (Supplemental Fig. S1).
Mesp1-Cre is expressed from E6.5 in the pharyngeal and cardiac me-
soderm, including both the first and second heart fields of meso-
dermal cardiac progenitors (Saga et al., 1999), and in situ hybridisation
(ISH) confirmed loss of Chd7 mRNA throughout the heart in E11.5
Chd7fl/fl;Mesp1-Cre embryos (Supplemental Fig. S2). No liveborn Chd7fl/
fl;Mesp1-Cre pups were produced from this cross, and at E18.5 the
number of Chd7fl/fl;Mesp1-Cre embryos collected were significantly
below their expected Mendelian ratios (Supplemental Table S1). Ap-
proximately three-quarters of Chd7fl/fl;Mesp1-Cre embryos survived to
E15.5, although over 90% (n¼22) showed severe oedema and/or
haemorrhaging, indicative of cardiac failure (Fig. 1A). This conditional
model therefore bypasses the p53-dependant developmental delay
and early embryonic lethality seenwith constitutive Chd7 / mutants,
allowing a fuller assessment of heart development and investigation
into the role of CHD7 in septation and great vessel remodelling.
Examination of the great arteries at E15.5 revealed that 21%
(n¼14) of Chd7fl/fl;Mesp1-Cre embryos had interrupted aortic arch
type B (IAA-B, Fig. 1B), compared to just 4% of heterozygous gene-
trapped Chd7xk/þ embryos (Randall et al., 2009). The great vessel
defects in Chd7xk/þ mutants were attributed to earlier pharyngeal
arch artery (PAA) malformations seen at E10.5, and Chd7 expres-
sion in the pharyngeal surface ectoderm – but not the mesoderm –
was shown to be required for this early PAA morphogenesis
(Randall et al., 2009). However, the PAAs were formed normally in
all E10.5 Chd7fl/fl;Mesp1-Cre embryos examined (n¼14, Fig. 1C),
presumably as the ectodermal expression of Chd7 is unaffected in
this genotype. Instead, the IAA-Bs seen at E15.5 were likely due to
a later PAA remodelling defect, indicating that Chd7 is required in
mesodermal derivatives for remodelling of the OFT and PAAs to
form the mature configuration of the aortic arch and great vessels.fl;Mesp1-Cre embryos showed severe oedema (arrow) and/or haemorrhaging com-
d7fl/fl embryos, whilst 21% of Chd7fl/fl;Mesp1-Cre embryos showed interrupted aortic
Chd7fl/fl;Mesp1-Cre embryo shown here to better visualise the great vessels. (C) Ink
aryngeal arch arteries (PAAs) in Chd7fl/fl (top panel) and Chd7fl/fl;Mesp1-Cre (bottom
ent (n¼14). Scale bars represent 1 mm (A), 0.5 mm (B) or 0.2 mm (C). rsc/lsc indicates
tflow tract; ra/la, right/left atrium; rv/lv, right/left ventricle.
Fig. 2. Structural defects affecting the arterial and venous poles. (A) Schematic to show the normal configuration of the heart in Chd7fl/fl controls, with complete separation of
the pulmonary (blue) and systemic (red) circulatory systems, compared to major septation and alignment defects seen in Chd7fl/fl;Mesp1-Cre hearts. These included inter-
rupted aortic arch type B (IAA-B-1), double outlet right ventricle (DORV-2) and double inlet left ventricle (DILV-3). (B) Transverse H&E sections through the heart at E15.5
showed normal morphology in Chd7fl/fl embryos, whilst DORV was present in 60% of Chd7fl/fl;Mesp1-Cre hearts, whereby both the pulmonary trunk (left panel) and the base
of the aorta (black arrow, right panel) arise from the right ventricle. (C) Common arterial trunk (CAT), where the outflow tract is not fully septated into a separate aorta and
pulmonary trunk, was seen in a Chd7fl/fl;Mesp1-Cre embryo collected at E13.5. An aortopulmonary window (star) can be seen, above a common set of valves. Normal OFT
septation was seen in all Chd7fl/fl controls. (D) All Chd7fl/fl;Mesp1-Cre hearts had DILV, including inter-ventricular communication (star, left panel), common AV valves (star,
right panel) and poor formation of the venous valves (green arrows). (E) The compact myocardial layer of the ventricular wall was thin when compared to Chd7fl/fl hearts
(compare double-headed arrows). The bar graph shows the mean thickness of the compact and trabecular layers of the ventricles, indicating that the overall thickness of
both the right and left ventricles was significantly reduced in Chd7fl/fl;Mesp1-Cre hearts. The percentage of the overall wall thickness that each layer comprised is also
indicated on the graph, showing the compact layer is particularly affected in the left ventricle of the mutants. nn po0.01 (calculated using unpaired student t test). Scale bars
represent 0.5 mm. ao indicates aorta; pt, pulmonary trunk; ra/la, right/left atrium; rv/lv, right/left ventricle; ivs, inter-ventricular septum.
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Correct alignment and septation of the developing cardiac
components ensures the complete separation of the pulmonary
and systemic circulations, which is vital for effective cardiovas-
cular function. Haematoxylin and eosin (H&E) staining of sections
showed major structural defects in Chd7fl/fl;Mesp1-Cre hearts
(summarised in Fig. 2A and Table 1). Sixty percent of hearts ex-
amined at E15.5 (n¼10) had double outlet arising from the right
ventricle (DORV, Fig. 2B), and common arterial trunk (CAT) was
seen in one Chd7fl/fl;Mesp1-Cre embryo at E13.5 (n¼10, Fig. 2C).Whilst these malformations are indicative of an abnormality in the
addition of second heart field (SHF)-derived cells to the arterial
pole, Islet-1 staining showed similar distributions of un-
differentiated SHF progenitors in the developing OFTs of control
Chd7fl/fl and mutant Chd7fl/fl;Mesp1-Cre hearts (Supplemental Fig.
S3). It may therefore be the subsequent differentiation of these
SHF-derived cells in Chd7fl/fl;Mesp1-Cre hearts that is underlying
the observed OFT defects.
All hearts examined at E15.5 also had double inlet left ventricle
(DILV, Fig. 2D), a severe form of AVSD whereby both atria are
connected through a common atrioventricular (AV) valve to a
Table 1
Cardiovascular defects observed at E15.5 in embryos from the Chd7fl/fl x Chd7fl/þ ;
Mesp1-Cre cross.
Genotype IAA-B AVSD DILV DORV Myocardial non-
compaction
Venous
valve defect
Chd7fl/þ 0/11 0/7 0/7 0/7 0/7 0/7
Chd7fl/fl 1/16 0/5 0/5 0/5 0/5 0/5
Chd7fl/þ ;
Mesp1-Cre
1/9 0/4 0/4 0/4 0/4 0/4
Chd7fl/fl;
Mesp1-Cre
3/14 10/10 10/10 6/10 8/10 9/10
IAA-B indicates interrupted aortic arch type B; AVSD, atrioventricular septal defect;
DILV, double inlet left ventricle; DORV, double outlet right ventricle.
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incomplete right ventricle. Related to this malformation, an inter-
ventricular communication was observed in all hearts, and the
venous valves were absent or poorly formed. Furthermore, the
ventricular mural myocardium was poorly compacted in Chd7fl/fl;
Mesp1-Cre hearts (Fig. 2E), although the development of the epi-
cardium looked normal (Supplemental Fig. S4).
The presence of AVSD and common AV valves is indicative of a
failure of the vestibular spine (also known as the dorsal me-
senchymal protrusion) to form at the venous pole of the heart. It is
this spine that drives the separation of the AV canal into its left
and right components and carries forward the inferior ends of the
venous valves (Anderson et al., 2003). To investigate this further,
optical projection tomography (OPT) was used to examine hearts
at E11.5, which showed the vestibular spine was absent or reduced
in size in Chd7fl/fl;Mesp1-Cre hearts (Fig. 3A). This imaging also
showed grossly abnormal positioning of the endocardial cushions,
which were markedly rotated within the AV canal compared to the
control hearts (Fig. 3B). These local tissue swellings contribute to
the septation of the chambers to form the functional four-cham-
bered heart, and a hypocellular AV cushion defect has been re-
ported in Chd7-null embryos at E9.5 and E10.5 (Liu et al., 2014).
Despite their abnormal positioning, a similar hypocellular defect
was not seen in the cushions of Chd7fl/fl;Mesp1-Cre hearts at E10.5
or E11.5 (Fig. 3C and Supplemental Fig. S5), indicating that me-
senchymal population of the cushions is not affected in these
conditional mutants.
The great vessel, OFT and septation defects we observed in
Chd7fl/fl;Mesp1-Cre hearts correlate well with the reported clinical
CHARGE malformations (Corsten-Janssen et al., 2013). However,
whilst AVSD is commonly seen, DILV is not usually associated with
CHARGE syndrome. This difference likely reflects dosage depen-
dence for Chd7 expression, with homozygous deletion of Chd7 in
the mesoderm resulting in a greater reduction in CHD7 activity
than occurs in CHARGE patients. Similarly, lack of haploinsuffi-
ciency in our heterozygous mesodermal conditional mutants in-
dicates that hemizygosity for the CHD7 protein is required in
multiple tissue types for the CHARGE phenotype to become
manifest. Interestingly, this combination of DILV with concordant
ventriculo-arterial connections seen in the Chd7fl/fl;Mesp1-Cre
hearts is analogous to the extremely rare condition in humans
known as the “Holmes heart” (Dobell and Van Praagh, 1996).
2.3. Defective cardiac innervation and coronary vein development
To characterise further the cardiac phenotype following me-
sodermal Chd7 ablation, the innervation and vascularisation of
these hearts was investigated. Wholemount immunostaining for
Neurofilament-66 showed major truncation of the neuronal axons
innervating Chd7fl/fl;Mesp1-Cre hearts (Fig. 4A). Both sympathetic
and parasympathetic axons can be seen on the dorsal surface ofthe heart by E15.0, although they are predominantly sympathetic
(Nam et al., 2013). They are derived from NCCs, which migrate to
the dorsal aorta, differentiate into neurons and extend axonal
projections into the cardiac tissue (Hasan, 2013). As Chd7 expres-
sion is not deleted in NCCs in Chd7fl/fl;Mesp1-Cre embryos, this is
indicative of a non-cell autonomous effect of mesodermal Chd7
knockdown on the NCCs or neurons that contribute to cardiac
innervation.
Major disruption to the coronary veins on the dorsal surface of
the heart was also seen at E15.5 in Chd7fl/fl;Mesp1-Cre hearts by
anti-Endomucin immunostaining, with either severe truncation of
vessels or ectopic formation of multiple small veins (Fig. 4B).
However, the coronary veins formed normally when Chd7 was
ablated specifically in endothelial cells using Tie2-Cre (Fig. 4C).
Therefore, CHD7 activity within the myocardium again appears to
have a non-cell-autonomous effect on the migratory endothelial
cells required for the development of the coronary veins, pre-
sumably through transcriptional effects on extracellular guidance
signalling from the myocardium to the venous endothelial cells.
2.4. Dissecting the role of CHD7 in the endocardium
The septation and trabeculation defects observed in Chd7fl/fl;
Mesp1-Cre hearts could be due to abnormal development of the
endocardium and its derivatives. We therefore addressed the im-
portance of CHD7 activity in this lineage by utilising the pan-en-
dothelial marker Tie2-Cre (Kisanuki et al., 2001) to drive en-
docardial-specific Chd7 ablation. Chd7fl/fl;Tie2-Cre offspring were
viable, and significantly fewer Chd7fl/fl;Tie2-Cre embryos collected
at E15.5 showed oedema compared with Chd7fl;fl;Mesp1Cre em-
bryos (see Table 2 and Fig. 5A). Furthermore, none showed hae-
morrhaging, indicating that CHD7 activity is not required cell au-
tonomously for vessel integrity. Some great vessel and septation
defects were present (Fig. 5B–C), and three out of eight Chd7fl/fl;
Tie2-Cre embryos showed a similar myocardial non-compaction
defect to Chd7fl;fl;Mesp1-Cre hearts. However, these malformations
were seen at a lower penetrance and without the accompanying
alignment defects seen following Mesp1-Cre-driven ablation.
There were also no examples of DORV or CAT seen in Chd7fl/fl;Tie2-
Cre embryos, suggesting that CHD7 activity in the endocardium is
not involved in arterial pole septation.
Together, this data indicates that there is indeed a role for Chd7
in the endocardium for AV canal septation and compaction of the
myocardial walls. However, as the full Chd7fl/fl;Mesp1-Cre cardiac
phenotype is not recapitulated in Chd7fl/fl;Tie2-Cre hearts, it may not
be the only underlying mechanism. Reciprocal interactions between
the endocardium and myocardium, which are both derived from
Mesp1-expressing progenitors, are crucial during heart develop-
ment (Tian and Morrisey, 2012). Therefore, it is likely the increased
severity and frequency of defects seen in Chd7fl/fl;Mesp1-Cre hearts
is due to a requirement for CHD7 activity in both lineages. Fur-
thermore, as Tie2-Cre also marks the venous precursors of the
lymphatic vasculature (Srinivasan et al., 2007), the absence of
haemorrhage and the low penetrance of oedema in Chd7fl/fl;Tie2-Cre
conditionals is not supportive of a major role for CHD7 in lymphatic
development. Instead, poor cardiac function is most likely to be
underlying these phenotypes in Chd7fl/fl;Mesp1-Cre embryos.
2.5. Differential gene expression following mesodermal Chd7
ablation
To investigate the global transcriptional changes underlying the
observed cardiovascular defects, microarrays were performed on
mRNA extracted from dissected Chd7fl/fl;Mesp1-Cre versus Chd7þ /
þ;Mesp1-Cre hearts. Gene expression was examined at both E11.5
and E13.5, when the growth of the vestibular spine, development
Fig. 3. E11.5 Chd7fl/fl;Mesp1-Cre hearts show loss of the vestibular spine and misaligned endocardial cushions. (A) Transverse (TRANS) OPT sections through a Chd7fl/fl heart
showed formation of the primary atrial septum (green arrows) and the vestibular spine (red arrow). The endocardial superior and inferior AV cushions were seen in separate
planes (yellow stars). In the Chd7fl/fl;Mesp1-Cre heart (A′) the atrial septum formed as expected (green arrows), but the vestibular spine was completely absent (red star). The
arrangement of the endocardial cushions was also grossly abnormal, with both seen adjacently in the same plane (yellow stars). (B) Digital re-slicing was used to produce
coronal (COR) sections of the same hearts, which highlighted the abnormal positioning of the endocardial cushions following mesodermal Chd7 ablation (B′, yellow stars).
(C) Morphology was also examined using H&E staining of coronal sections at E11.5, to better view the cushions of the OFT and AV canal. Despite their abnormal positioning
within the AV canal, mesenchymal population of the cushions does not appear to be affected in mutants. Scale bars represent 0.2 mm. oft indicates outflow tract; rv, right
ventricle; lv, left ventricle; a, atrium; v, ventricle; avc, atrioventricular canal.
S. Payne et al. / Developmental Biology 405 (2015) 82–9586of the endocardial cushions, and septation is normally occurring.
Crucially, most cardiovascular defects occurred later in our con-
ditional model than on the background of global Chd7 knockdown
and gross developmental delay, with no major loss of tissue or
hypocellular phenotype in either E10.5 or E11.5 Chd7fl/fl;Mesp1-Cre
hearts. Therefore, our analysis of a role for CHD7 subsequent to its
previously-reported BMP-dependant role upstream of Nkx2.5
should not be compromised by earlier defects (Liu et al., 2014).
Furthermore, Western blot analysis of CHD7 protein in dissected
wild-type hearts showed CHD7 was detectable until E13.5, whilst
nuclear CHD7 protein was observed by immunohistochemistrythroughout wild-type hearts at E10.5 and E11.5 (Supplemental
Fig. S6). This indicates a later role for CHD7 in cardiovascular de-
velopment than can be examined in constitutive Chd7 /
mutants.
Full lists of genes with altered expression (log2 FC40.5, po0.05)
in the heart at E11.5 or E13.5 following mesodermal deletion of Chd7
are available in Supplemental Table S2. Multiple testing correction
using the Benjamini–Hochberg procedure identified 31 genes that
were significantly downregulated and 20 genes upregulated at E11.5,
whilst 6 genes were downregulated and 3 upregulated at E13.5
(log2 FC40.5, adj. po0.05-see Table 3). This is consistent with
Fig. 4. Chd7fl/fl;Mesp1-Cre hearts have defective innervation and coronary vein development. (A–A′) Wholemount immunostaining at E15.0 for Neurofilament-66 allowed
visualisation of the sympathetic and parasympathetic innervation descending from the cardiac plexus and branching into the ventricles (white arrows). Severe truncation of
axons was seen in Chd7fl/fl;Mesp1-Cre hearts (stars, A′). (A″) Quantification of the innervation defects: Chd7fl/fl;Mesp1-Cre hearts (n¼4) showed significantly fewer axonal
branch points viewed on the dorsal surface of the heart than in Chd7fl/fl controls (n¼5). The percentage of the dorsal ventricular surface area covered by the extending axons
was also measured and found to be significantly reduced from a mean value of 57% in controls to 27% in mutants. (B–C) Dorsal view of E15.5 hearts immunostained with anti-
Endomucin showed formation of three main coronary veins in control hearts (white arrows, B). In Chd7fl/fl;Mesp1-Cre hearts, patterning of the veins was clearly disrupted,
with either severely truncated of vessels or additional smaller vessels seen (stars, B′ and B″). However, coronary vein development was normal in Chd7fl/fl;Tie2-Cre hearts
(arrows, C). n po0.05, nn po0.01 (unpaired student t test). Scale bars represent 2 mm. Cp indicates cardiac plexus.
Table 2
Comparison of cardiovascular defects observed at E15.5 in Chd7fl/fl;Tie2-Cre and
Chd7fl/fl;Mesp1-Cre embryos.
Chd7fl/fl;Tie2-Cre Chd7fl/fl;Mesp1-Cre
Oedema 18% 68%
Haemorrhage 0% 64%
IAA-B 12.5% 21%
AVSD 12.5% 100%
DILV 0% 100%
VSD only 25% N/A
ASD only 12.5% N/A
DORV 0% 60%
Myocardial non-compaction 37.5% 80%
Venous valve defects 0% 90%
Viable? Yes – 5/8 No – 0/9
Genotypes were recorded as viable if live pups were recorded at P10, the numbers
indicate the number of observed pups compared to the expected number based on
Mendelian ratios. Numbers of Chd7fl/fl;Mesp1-Cre embryos examined are shown in
Table 1. For Chd7fl/fl;Tie2-Cre, n¼11 for external phenotypes and n¼8 for great
vessel and cardiac defects.
IAA-B indicates interrupted aortic arch type-B; AVSD, atrioventricular septal defect;
VSD, ventricular septal defect; ASD, atrial septal defect; DILV, double inlet left
ventricle; DORV, double outlet right ventricle.
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“transcriptional rheostat” to modulate the expression of its target
genes in either a positive or negative direction (Schnetz et al., 2010).
Gene ontology (GO) term clusters generated using the DAVID
Bioinformatics resource (Huang et al., 2009) highlighted a number of
processes relevant for later cardiac development and the defects
observed in the Chd7fl/fl;Mesp1-Cre hearts (Supplemental Tables
S3–6). Interestingly, many of the GO clusters involved extracellular
signalling pathways, such as cell surface receptor linked signal
transduction and G-protein coupled receptor signalling pathways,
rather than direct transcriptional regulators such as Nkx2.5 andTbx20, which are downregulated in earlier Chd7-null hearts (Liu et al.,
2014).
We chose to investigate further components of the Semaphorin
and Slit–Robo extracellular signalling pathways that were dis-
rupted in the microarray datasets, alongside genes involved in the
excitation–contraction coupling of cardiomyocytes, due to their
known roles in cardiovascular development and relevance to the
observed defects in Chd7fl/fl;Mesp1-Cre hearts (see Supplemental
Table S7).
2.6. Disruption to Class 3 Semaphorin and Slit–Robo signalling
pathways
The signalling glycoprotein Semaphorin 3A, encoded by Se-
ma3a, acts as a potent neural chemorepellent and has a key role in
sympathetic innervation patterning of the heart: homozygous null
Sema3a / mice show disruption to cardiac innervation leading to
sinus bradycardia (Ieda et al., 2007). Sema3a expression was sig-
nificantly downregulated in both the E11.5 and E13.5 microarray
datasets (Table 3), and RT-PCR and ISH confirmed the trabecular
expression of Sema3a seen at E13.5 was drastically reduced fol-
lowing mesodermal Chd7 ablation (Fig. 6A and B). This down-
stream loss of Sema3A expression may be contributing to the in-
nervation defects seen in Chd7fl/fl;Mesp1-Cre hearts. Alternatively,
given the location of its expression at this stage, it may be influ-
encing the trabeculation and compaction of the ventricles, which
are also affected in Chd7fl/fl;Mesp1-Cre hearts.
Loss-of-function mutations of SEMA3A are associated with hu-
man Kallmann Syndrome (Hanchate et al., 2012), a disorder having
defects overlapping with CHARGE. Of interest, non-synonymous
SEMA3A variations have been found in 3 of 45 CHD7-negative
CHARGE patients, and Sema3a expression is lost after morpholino-
knockdown of Chd7 in Xenopus (Schulz et al., 2014). This work
therefore strengthens the link between CHD7 and SEMA3A and
Fig. 5. Endocardial ablation of Chd7 results in less severe cardiovascular defects. (A) Mild oedema (left panel) was seen in just 18% of Chd7fl/fl;Tie2-Cre embryos collected at
E15.5 (n¼11), whilst the majority of these embryos had a normal external appearance (right panel). (B) One Chd7fl/fl;Tie2-Cre embryo examined showed interrupted aortic
arch type B (IAA-B, star), as also seen in Chd7fl/fl;Mesp1-Cre embryos. (C–C′) Two examples of H&E transverse sections through E15.5 Chd7fl/fl;Tie2-Cre hearts, both of which
show normal septation and alignment of the OFT (far left panels). The first (C) shows inter-ventricular communication associated with a balanced atrio-ventricular septal
defect (AVSD, stars), and a thin myocardial wall in the right ventricle. The second (C′) shows a milder phenotype of ventricular septal defect (VSD, star in middle panel) with
normal AV canal septation (right panel). Scale bars represent 1 mm (A) or 0.5 mm (B–C). rsc indicates right subclavian artery; rcc/lcc, right/left common carotid artery; ao, aorta;
pt, pulmonary trunk; rv/lv, right/left ventricle; ra/la, right/left atrium.
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cardiac innervation. Furthermore, it is in agreement with, and
extends, a recent report that Sema3a and Sema3c have diminished
expression in whole E9.5 Chd7 / embryos (Schulz et al., 2014).
Downregulation of Sema3c expression was also seen in the
microarrays and qRT-PCR validation. ISH at E11.5 confirmed Se-
ma3c expression is specifically lost in the myocardial cuff at the
distal end of the OFT in Chd7fl/fl;Mesp1-Cre hearts (Fig. 6C). Notably,
Sema3c-/- embryos have defects in the morphogenetic patterning
of the aortic arch and OFT that significantly overlap with Chd7fl/fl;
Mesp1-Cre hearts, including CAT, DORV and IAA-B (Feiner et al.,
2001). Earlier PAA formation is also unaffected in these embryos,
as we observe in Chd7fl/fl;Mesp1-Cre embryos. Chromatin im-
munoprecipitation (ChIP) for CHD7 followed by qRT-PCR per-
formed on chromatin from dissected E11.5 hearts showed en-
richment for CHD7 specifically at the promoter region of Sema3c
(Fig. 6D and E). DNase I hypersensitivity assays, designed to testthe accessibility of this region of DNA as a readout of chromatin
remodelling activity, also showed a significant reduction in sen-
sitivity to increasing concentrations of DNase I in Chd7fl/fl;Mesp1-
Cre hearts (Fig. 6F). This is the first direct target for CHD7 reg-
ulation in the heart to be identified in vivo, and supports our
proposal that diminished Semaphorin 3C signalling in the OFT
contributes to the defects seen in Chd7fl/fl;Mesp1-Cre hearts.
A number of components of the Slit–Robo signalling pathway
were similarly downregulated following Chd7 ablation, including Slit2,
Robo2, Slitrk5 and Slitrk6 (Fig. 7A–C). The Slit and Robo protein fa-
milies participate together in repulsive or attractive signalling to a
range of migrating cells, including neurons (Rothberg et al., 1988),
muscle precursors (Kramer et al., 2001), and endothelial cells (Zhang
et al., 2009). The observation of truncated coronary veins after me-
sodermal, but not endothelial, deletion of Chd7 therefore may be at-
tributed, at least in part, to downregulation of Slit–Robo signalling
Table 3
Genes identified through microarray analysis with differential expression in Chd7fl/fl;Mesp1-Cre hearts following multiple testing correction (log2 FC40.5, adj.p.value
o0.05).
Ensembl ID Symbol Chrom Description log2 FC p-Value Adj.p.value
E11.5
ENSMUSG00000041235 Chd7 4 Chromodomain helicase DNA binding protein 7 1.68 6.11E09 0.000212
ENSMUSG00000031558 Slit2 5 Slit homologue 2 (Drosophila) 0.987 2.44E08 0.000283
ENSMUSG00000035551 Igfbpl1 4 Insulin-like growth factor binding protein-like 1–1.30 1.08E07 0.000939
ENSMUSG00000019787 Trdn 10 Triadin 1.08 6.84E07 0.00238
ENSMUSG00000039579 Grin3 a 4 Glutamate receptor ionotropic, NMDA3A 0.972 6.21E07 0.00238
ENSMUSG00000028883 Sema3a 5 Semaphorin 3A 0.894 9.87E07 0.00264
ENSMUSG00000018893 Mb 15 Myoglobin 1.20 3.24E06 0.00593
ENSMUSG00000024868 Dkk1 19 Dickkopf homologue 1 (Xenopus laevis) 1.23 1.13E05 0.0127
ENSMUSG00000004151 Etv1 12 ets Variant gene 1–0.614 1.11E05 0.0127
ENSMUSG00000019906 Lin7a 10 Lin-7 homologue A (C. elegans) 1.57 1.80E05 0.0179
ENSMUSG00000044067 Gpr22 12 G protein-coupled receptor 22 0.839 2.11E05 0.0188
ENSMUSG00000052516 Robo2 16 Roundabout homologue 2 (Drosophila) 0.907 2.38E05 0.0201
ENSMUSG00000074491 Clec4g 8 C-type lectin domain family 4, member g 0.986 2.52E05 0.0203
ENSMUSG00000069171 Nr2f1 13 Nuclear receptor subfamily 2, group F, member 1–1.24 4.09E05 0.0277
ENSMUSG00000016494 Cd34 1 CD34 antigen 0.647 4.14E05 0.0277
ENSMUSG00000073764 Gm12888 4 Predicted gene 12888 0.837 4.38E05 0.0282
ENSMUSG00000027463 Slc52a3 2 Solute carrier protein family 52, member 3–1.37 4.54E05 0.0287
ENSMUSG00000007653 Gabrb2 11 Gamma-aminobutyric acid (GABA) A receptor, subunit beta 2–0.821 5.02E05 0.0292
ENSMUSG00000020061 Mybpc1 10 Myosin binding protein C, slow-type 1.25 5.32E05 0.0303
ENSMUSG00000025488 Cox8b 7 Cytochrome c oxidase, subunit VIIIb 1.17 6.16E05 0.0323
ENSMUSG00000020682 Mmp28 11 Matrix metallopeptidase 28 (epilysin) 0.564 6.10E05 0.0323
ENSMUSG00000026678 Rgs5 1 Regulator of G-protein signalling 5–2.04 6.76E05 0.0340
ENSMUSG00000049537 Tecrl 5 Trans-2,3-enoyl-CoA reductase-like 0.643 6.93E05 0.0341
ENSMUSG00000022519 Srl 16 Sarcalumenin 0.550 7.58E05 0.0346
ENSMUSG00000033737 Fndc3c1 X Fibronectin type III domain containing 3C1 1.07 8.05E05 0.0354
ENSMUSG00000059742 Kcnh7 2 Potassium voltage-gated channel, subfamily H (eag-related), member 7 0.992 8.03E05 0.0354
ENSMUSG00000039057 Myo16 8 Myosin XVI 0.717 0.000113 0.0446
ENSMUSG00000055639 Dach1 14 Dachshund 1 (Drosophila) 0.673 0.000117 0.0450
ENSMUSG00000019851 Perp 10 PERP, TP53 apoptosis effector 0.650 0.000118 0.0450
ENSMUSG00000061080 Lsamp 16 Limbic system-associated membrane protein 0.577 0.000116 0.0450
ENSMUSG00000023328 Ache 5 Acetylcholinesterase 0.799 0.000137 0.0497
ENSMUSG00000070867 Trabd2b 4 Predicted gene 12824 0.860 2.19E06 0.00475
ENSMUSG00000021219 Rgs6 12 Regulator of G-protein signalling 6 0.895 4.07E06 0.00615
ENSMUSG00000029322 Plac8 5 Placenta-specific 8 1.82 5.56E06 0.00773
ENSMUSG00000025196 Cpn1 19 Carboxypeptidase N, polypeptide 1 1.47 6.39E06 0.00854
ENSMUSG00000022103 Gfra2 14 Glial cell line derived neurotrophic factor family receptor alpha 2 1.19 8.69E06 0.0108
ENSMUSG00000096555 Olfr944 9 Olfactory receptor 944 0.650 3.25E05 0.0236
ENSMUSG00000069583 Krtap12-1 10 Keratin associated protein 12-1 0.558 4.05E05 0.0277
ENSMUSG00000053519 Kcnip1 11 Kv channel-interacting protein 1 0.943 4.62E05 0.0287
ENSMUSG00000051251 Nhlh1 1 Nescient helix loop helix 1 0.676 5.73E05 0.0321
ENSMUSG00000095241 Gm5478 15 0.732 5.85E05 0.0322
ENSMUSG00000097451 Rian NA NA 0.746 8.35E05 0.0363
ENSMUSG00000027942 4933434E20Rik 3 RIKEN cDNA 4933434E20 gene 1.73 9.34E05 0.0396
ENSMUSG00000031825 Crispld2 8 Cysteine-rich secretory protein LCCL domain containing 2 0.587 9.84E05 0.0412
ENSMUSG00000029309 Sparcl1 5 SPARC-like 1 0.723 0.000106 0.0433
ENSMUSG00000070933 Speer4d 5 Spermatogenesis associated glutamate (E)-rich protein 4d 0.878 0.000110 0.0445
ENSMUSG00000058952 Cfi 3 Complement component factor i 1.10 0.000113 0.0446
ENSMUSG00000020427 Igfbp3 11 Insulin-like growth factor binding protein 3 0.854 0.000120 0.0453
ENSMUSG00000040653 Ppp1r14 c 10 Protein phosphatase 1, regulatory (inhibitor) subunit 14c 0.586 0.000123 0.0461
E13.5
ENSMUSG00000041235 Chd7 4 Chromodomain helicase DNA binding protein 7 1.58 1.41E08 0.000489
ENSMUSG00000069171 Nr2f1 13 Nuclear receptor subfamily 2, group F, member 1–1.43 8.43E06 0.0366
ENSMUSG00000023964 Calcr 6 Calcitonin receptor 1.39 1.04E05 0.0403
ENSMUSG00000073007 Fam46d X Family with sequence similarity 46, member D 1.11 1.24E05 0.0425
ENSMUSG00000033214 Slitrk5 14 SLIT and NTRK-like family, member 5–0.670 1.35E05 0.0425
ENSMUSG00000028883 Sema3 a 5 Semaphorin 3A 0.704 1.63E05 0.0437
ENSMUSG00000025196 Cpn1 19 Carboxypeptidase N, polypeptide 1 1.93 2.32E07 0.00404
ENSMUSG00000055312 0610012H03Rik 2 RIKEN cDNA 0610012H03 gene 0.911 3.92E06 0.0273
ENSMUSG00000069792 Wfdc17 11 Predicted gene 11428 1.61 7.76E06 0.0366
Chrom. indicates chromosome. Fold changes are given on a binary logarithmic scale (log2 FC), P.values of significance were calculated using a Bayes moderated t test, whilst
adj.p.values of significance were calculated using the Benjamini and Hochberg False Discovery Rate process. Numerical values are shown to 3 significant figures.
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phorin and Slit–Robo signalling have been shown to act synergisti-
cally for directional control of neuronal migration in the context of
both ventral forebrain and corneal innervation (Hernandez-Miranda
et al., 2011; Kubilus and Linsenmayer, 2010). The compound effect of
disruption to components of both pathways could therefore impacton the innervation defects present in Chd7fl/fl;Mesp1-Cre hearts. Fur-
thermore, the Slit–Robo pathway is crucial for ventricular septation,
with VSDs observed at E14.5 in mice mutant for Slit2, Slit3, Robo1 and
Robo1/Robo2 double mutants (Mommersteeg et al., 2015). Also of
note, reduced outflow tract rotation was observed in the Robo1/
Robo2 mutants (Mommersteeg et al., 2015).
Fig. 6. CHD7 regulates Class 3 Semaphorin expression in the developing heart. (A) Real-time PCR comparing expression of Class 3 Semaphorin genes in Chd7þ /þ;Mesp1-Cre
and Chd7fl/fl;Mesp1-Cre dissected hearts at E11.5 and E13.5. Supplemental Table S7 shows the microarray results for these genes for comparison. (B) At E13.5, trabecular
expression of Sema3A was seen by ISH on control Chd7fl/fl sections, with significant reduction in Chd7fl/fl;Mesp1-Cre hearts (red stars). (C) ISH at E11.5 showed Sema3C
expression in the myocardial cuff (blue arrows), which was strongly downregulated at the distal end of the OFT in Chd7fl/fl;Mesp1-Cre hearts (red arrows). Sema3C expression
in the cardiac neural crest was also slightly reduced in mutants (white arrows). (D) ENCODE data around the Sema3c locus was used to design primer sets (denoted in red) to
overlap with areas of DNase I hypersensitivity and histone modification marks associated with suspected promoter and enhancer regions. (E) ChIP-PCR demonstrated CHD7
binding around the promoter of Sema3C at E11.5 using Primer pair 1. (F) DNase I hypersensitivity assay showed greater chromatin compaction in Chd7fl/fl;Mesp1-Cre hearts
(dotted line) than littermate controls (solid line) at the Sema3c promoter. Little change was seen at the Gapdh or Nanog promoters, although Gapdh displayed greater
hypersensitivity, correlating with its constitutive expression. Individual replicates are shown, as it was not possible to normalise across separate experiments. n po0.05,
nn po0.01 (unpaired student t test). Scale bars represent 0.2 mm. oft indicates outflow tract; rv, right ventricle; lv, left ventricle.
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of the key Semaphorin and Slit–Robo extracellular signalling
pathways in the heart around E11.5–E13.5, with CHD7 binding
observed in vivo at the promoter of Sema3c suggesting directregulation. Unfortunately, due to technical difficulties attempts at
in vivo ChIP-seq or ChIP-PCR at other candidate loci were un-
successful, so it remains to be determined whether other gene
expression changes are the result of direct CHD7 activity.
Fig. 7. Disruption to the Slit–Robo pathway in Chd7fl/fl;Mesp1-Cre hearts. (A) Real-time PCR also showed disruption to Slit–Robo pathway genes in Chd7fl/fl;Mesp1-Cre hearts
compared to Chd7þ /þ;Mesp1-Cre at E11.5 and E13.5. Supplemental Table S7 shows the microarray results for these genes. (B) Slit2 expression is seen by ISH in the trabeculae at E13.5,
with staining greatly reduced in Chd7fl/fl;Mesp1-Cre hearts (red stars). Sections through the neural tube of the same embryos are shown as an internal positive control for Slit2
expression (right), showing the loss of expression is specific toMesp1-derived tissue. (C) Robo2 expression seen in the cushions of the proximal OFT (blue arrows) was lost in Chd7fl/fl;
Mesp1-Cre hearts (red arrows). n po0.05, nn po0.01 (unpaired student t test). Scale bars represent 0.2 mm. oft indicates outflow tract; rv, right ventricle; lv, left ventricle; nt, neural tube.
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Fig. 8. Impairment of excitation–contraction coupling in Chd7fl/fl;Mesp1-Cre cardiomyocytes. (A) Real-time PCR confirmed downregulation of selected Ca2þ handling genes
in Chd7fl/fl;Mesp1-Cre dissected hearts at E11.5 and E13.5. Supplemental Table S7 shows the microarray results for these genes. (B) Immunocytochemistry showed cardiac-
specific myosin heavy chain 6 (MHC6) and nuclear NKX2-5 levels in isolated E13.5 cardiomyocytes. (C) Rapid line scan analysis of Ca2þ transients over 40 s in individual
cardiomyocytes showed irregular contractions, which could be paced using electrical field stimulation at 1 Hz. (D) Comparison of 10 representative control Chd7fl/þ or Chd7fl/
fl line scans (top panel) with Chd7fl/fl;Mesp1-Cre (bottom panel) showed a range of pacing defects in Chd7fl/fl;Mesp1-Cre cardiomyocytes. Only one control cell tested did not
pace fully (far right of top panel). (E) Significantly fewer Chd7fl/fl;Mesp1-Cre cells responded to the electrical pacing compared to control cells. n po0.05, nn po0.01 (unpaired
student t test), nnn po0.0001 (two-tailed Fisher's exact test). Scale bars in B represent 0.1 mm.
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cardiomyocytes
In addition to the major morphological events involved in heart
development, the ability of cardiomyocytes to undergo co-
ordinated excitation–contraction coupling is essential for cardio-
vascular function. The ubiquitous messenger Ca2þ is the key sig-
nalling molecule for this process (Bers, 2002). Transcripts for the
sarcoplasmic reticulum (SR) membrane-associated Casq2, Trdn and
Ryr3, which play key roles in Ca2þ-induced Ca2þ release during
excitation–contraction coupling, were dysregulated, along with
the L-type voltage-dependant Ca2þ channels Cacng7, Cacna2d3
and Cacna1e (see Table S7 and Fig. 8A).
To determine whether the sum of these moderate transcrip-
tional changes correlated with any functional effect, Ca2þ tran-
sients were visualised in embryonic cardiomyocytes ex vivo, using
confocal microscopy for line scanning of individual cells over time
(Fig. 8B and C). A striking difference was observed in the response
to electrical field stimulation at 1 Hz between control (Chd7fl/fl orChd7fl/þ) and Chd7fl/fl;Mesp1-Cre cardiomyocytes: 95% (n¼22) of
control cells responded to electrical pacing with regular Ca2þ
transients recorded at the expected 1 s intervals, but only 39%
(n¼23) of Chd7fl/fl;Mesp1-Cre cells could be paced in this way
(po0.0001, Fig. 7D,E). This indicates the excitation–contraction
coupling mechanism in cardiomyocytes is defective following ab-
lation of Chd7 in the cardiogenic mesoderm.
The loss of coordinated excitation–contraction coupling would
be a major contributing cause of cardiac failure, which is likely
underlying the severe oedema and embryonic lethality seen in
Chd7fl/fl;Mesp1-Cre embryos. The importance of this cardiac failure
is emphasised given the low level of oedema seen in Chd7fl/fl;Tie2-
Cre embryos, as previously discussed. Ca2þ signalling is also an
important factor in regulating cardiac morphogenesis, for example
through secretion of cardiogenic signalling molecules and force
generation (Puceat and Jaconi, 2005). To our knowledge, dysre-
gulation of Ca2þ handling genes has not been remarked upon in
any other transcriptomics analysis of hearts mutant for chromatin
regulators. Interestingly, however, embryos mutant for the splicing
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scripts, leading to abnormal Ca2þ release from the SR and struc-
tural cardiac defects markedly similar to those seen in Chd7fl/fl;
Mesp1-Cre hearts (Feng et al., 2009). Transcriptional changes to
these genes and the resulting disruption to Ca2þ signalling
therefore also likely contribute to the structural malformations
observed in Chd7fl/fl;Mesp1-Cre hearts.3. Conclusions
We have demonstrated a crucial role for CHD7 activity in the
mesodermal lineage for the alignment, septation and maturation
of the heart, as well as cardiac innervation, vascularisation, and
remodelling of the great vessels. Ablation of Chd7 in the cardio-
genic mesoderm is sufficient to produce major structural defects
and disrupted cardiomyocyte function, with the bypass of early
lethality allowing the exploration of global transcriptional effects
on later heart development. This analysis indicated a switch in the
types of genes CHD7 regulates (directly or indirectly) as cardio-
genesis progresses, from transcription factors such as NKX2-5, to
extracellular signalling and Ca2þ handling genes. Furthermore,
Sema3c is identified as a novel direct target of CHD7 in the de-
veloping heart in vivo. Therefore, disruption to transcriptional
networks in both the cardiac neural crest and cardiogenic meso-
derm likely contribute to the cardiovascular defects seen in
CHARGE patients due to haploinsufficient loss of CHD7 activity.4. Materials and methods
Further details of Materials and methods are included in the
Supplemental material.
4.1. Mouse lines
Animal maintenance, husbandry and procedures were carried
out in accordance with British Home Office regulations. The mouse
lines used were: conditional Chd7fl (MGI: 4433295, Chd7tm2a(EU-
COMM)Wtsi),Mesp1-Cre (MGI: 2176467,Mesp1tm2(cre)Ysa), and Tie2-Cre
(MGI: 2450311,Tg(Tek-cre)1Ywa). All lines were maintained on a
C57Bl/6 J background. CD1 mice were used for CHD7 immuno-
fluorescence and ChIP experiments. The date of observation of a
vaginal plug was considered embryonic day E0.5.
4.2. Optical projection tomography
Embryos were fixed overnight in 4% PFA/PBS and mounted in
low-melting agarose (Life Technologies). Samples were then
trimmed and washed in 100% methanol followed by clearing in
2BA:1BB (2 parts benzyl alcohol to 1 part benzyl benzoate), before
analysis using a Bioptonics OPT Scanner 3001M (MRC Technology,
Edinburgh, UK). NRecon software (Skyscan NV) was used for image
reconstruction from projections using a back-projection algorithm,
and ImageJ was used for image analysis.
4.3. Microarrays
E11.5 or 13.5 hearts were dissected into RNase-free PBS and
stored in Buffer RLT (Qiagen) at 80 °C until genotyped. Total RNA
was isolated using RNeasy Mini kits (Qiagen), including the op-
tional on-column DNase digestion step. Sense-strand cDNA was
generated using the Ambions WT Expression Kit and processed
for hybridisation onto the Affymetrix Mouse Gene 1.0 ST Array
according to manufacturer's protocols. Scanning was performed
on the Affymetrix GeneChip Scanner. For each time point fourbiological replicates were run in each group: cDNA from four in-
dividual Chd7fl/fl;Mesp1-Cre hearts was compared to cDNA from
four Chd7þ /þ;Mesp1-Cre hearts. The data was normalised with the
RMA normalisation algorithm using the Affy R package (Gautier
et al., 2004) provided as part of the Bioconductor libraries (Gen-
tleman et al., 2004) and analysed for differential expression using
LIMMA (Smyth, 2004). Data has been submitted to GEO (accession
number GSE59963). The 100 significantly-altered genes with the
highest fold changes from each up- or down-regulated list from
the microarrays were uploaded to the DAVID Bioinformatics re-
source for GO analysis (Huang et al., 2009).
4.4. In situ hybridisation on paraffin sections
Plasmids for synthesising antisense RNA probes were kindly
donated from the following sources: Sema3a and Sema3c from
Christiana Ruhrberg; Robo2 from Gail Martin; and Slit2 from Bill
Andrews (original clone from David Ornitz's lab). The Chd7 probe
was generated using TOPOs TA Clonings Kits (Life Technologies)
with previously reported primers (Bosman et al., 2005). Details for
digoxigenin-labelling of probes, hybridisation and visualisation are
included in the Supplemental material.
4.5. ChIP-PCR
Hearts were dissected from wildtype E11.5 CD1 embryos and
sequentially fixed in 2 mM di(N-succinimidyl) glutarate (Sigma)
for 45 min and 1% formaldehyde for 15 min. Hearts were quen-
ched in 0.125 M glycine (Sigma) and washed in cold PBS. Tissue
was lysed and passed through 21G and 23G needles five times
each. Cells were pelleted by centrifugation and chromatin was
released in 1% SDS buffer and sheared using a BioRuptor Sonicator
(Diagenode), to an average size of 500 bp. All steps included 1
protease inhibitor cocktail (Roche).
ChIP was performed as described previously (Burney et al.,
2013) with antibodies specific to CHD7 (#6505, Cell Signalling
Technology) or non-specific rabbit IgG (Santa Cruz). Enrichment
was analysed by real-time PCR performed using locus-specific
primers (see Supplemental Material for sequences). Data were
normalised to 5% input and compared to enrichment at non-spe-
cific loci.
4.6. DNase I hypersensitivity assay
Individual E11.5 hearts were dissected in cold PBS and in-
cubated in 0.05% Trypsin-EDTA (Life Technologies) containing
10 mg/ml DNase I (Sigma) at 37 °C for 45 min. Trypsin was in-
hibited with 10% FBS (Life Technologies) and samples passed
through a 23G needle three times. Cells were pelleted by cen-
trifugation and nuclei released in lysis buffer (10 mM Tris pH7.4,
10 mM NaCl, 3 mM MgCl2, 0.1% NP40). Nuclei were treated with
increasing concentrations of DNase I (Promega) at 37 °C for
10 min. 25 mM EDTA was added to stop reactions and samples
were RNaseA and Proteinase K treated, before purification using a
Qiaquick PCR purification kit. Eluted DNA was quantified using a
Qubit fluorometer (Life Technologies) and diluted to the same
concentration, before RT-PCR analysis using primers designed
around gene promoters (see Supplemental material for
sequences).
4.7. Measurement of Ca2þ transients in embryonic cardiomyocytes
Individual Chd7fl/fl, Chd7fl/þ or Chd7fl/fl;Mesp1-Cre E13.5 hearts
were dissected in cold PBS and incubated in 0.05% Trypsin-EDTA
(Life Technologies) containing 10 mg/ml DNase I (Sigma) at 37 °C
for 45 min. Trypsin was inhibited with 10% FBS (Life Technologies)
S. Payne et al. / Developmental Biology 405 (2015) 82–9594and samples passed through a 23G needle three times. Cells were
pelleted by centrifugation and resuspended in 1 ml culture med-
ium (DMEM, 10% FCS, 1 PenStrep, 1 Non-essential amino
acids) before plating for 1.5 h to allow adherence of fibroblasts.
The supernatant containing cardiomyocytes was then plated onto
laminin-coated (Sigma) coverslip dishes, and cells cultured at
37 °C, 5% CO2 for 36 h. Plating efficiency and survival of Chd7fl/fl;
Mesp1-Cre cells did not appear compromised.
For imaging, cells were washed once in imaging buffer
(156 mM NaCl, 3 mM KCl, 2 mM MgSO4 7H20, 1.25 mM K2HPO4,
2 mM CaCl2, 10 mM HEPES, 10 mM D-Glucose, pH7.4) before in-
cubation at 37 °C for 10 min in imaging buffer/Opti-MEMs (50/50,
Life Technologies) containing the Ca2þ-sensitive fluorogenic dye
5 mM Cal-520™ (Stratech). A Leica SP5 confocal inverted micro-
scope performed rapid line scan analysis (400 Hz) of Ca2þ tran-
sients in individual cells (ex: 488 nm, em: 500–600 nm). Cells
producing Ca2þ transients were chosen randomly and were elec-
trically paced by field stimulation at 1 Hz using platinum elec-
trodes. Data was collected and analysed by averaging values across
the line, over time, using Leica LAS AF software. “Paced” cells were
classified as those in which Ca2þ transients were observed every
1 Hz over a 40 s interval, whereas in “non-paced” cells, Ca2þ
transients were absent or unsynchronised. p-values were calcu-
lated using two-tailed Fisher's exact test.Author Contributions
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